期刊文献+

肿瘤坏死因子-α在缓激肽开放血肿瘤屏障过程中的作用 被引量:1

The role of tumor necrosis factor-alpha play in the opening of blood-tumor barrier by bradykinin
暂未订购
导出
摘要 目的:探讨肿瘤坏死因子-α(TNF-α)在缓激肽(BK)开放血肿瘤屏障(BTB)过程中的作用。方法:缓激肽处理C6细胞和胶质瘤大鼠后,放射免疫法动态监测培养液和脑胶质瘤组织内TNF-α浓度。利用伊文思蓝连续监测缓激肽/TNF-α处理后的C6恶性胶质瘤大鼠血肿瘤屏障的通透性,同时电镜观察血肿瘤屏障的病理学改变。结果:缓激肽可增加C6细胞培养液和胶质瘤大鼠肿瘤组织内的TNF-α含量,且两者均于给予缓激肽后15min时达高峰(与对照组相比有显著统计学意义,P<0.01)。TNF-α与缓激肽单独作用于C6动物后,均可引起胶质瘤大鼠的血肿瘤屏障紧密连接开放及通透性增加。且肿瘤坏死因子-α对肿瘤模型动物血肿瘤屏障通透性的影响与C6细胞培养液中TNF-α含量相一致。结论:缓激肽开放血肿瘤屏障过程中,可能是通过某种机制引起肿瘤组织内TNF-α增加,增加的TNF-α进而引起了血肿瘤屏障的开放。 Objective To investigate the role of tumor necrosis factor-alpha (TNF-α) play in the opening of blood-tumor barrier (BTB) by bradykinin. Methods C6 cells and rats with glioma were administered with bradykinin, then the contents of TNF-α in the culture fluid of C6 cells and glioma tissues were measured by radioimmunoassay. The permeability and pathology of BTB in rats after bradykinin administration were observed by Evans blue (EB) and electron microscopy. Results The contents of TNF-α were obviously increased in the culture fluid of C6 cells and glioma tissues (as compared with control group, P 〈 0.01) after bradykinin administration, and reached their peak 15 rain later. The tight junction of BTB was opened and the permeability was increased in rats administered with bradykinin. The effect of TNF-α on the permeability of BTB in rats were similar to that in the culture fluid. Conclusion The opening of BTB by bradykinin may mediated by the increase of TNF-α
出处 《实用医学杂志》 CAS 北大核心 2012年第6期899-902,共4页 The Journal of Practical Medicine
基金 国家自然科学基金资助项目(编号:81101912) 河北省卫生厅科研基金项目(编号:20100464 20110165) 河北联合大学博士启动基金项目(编号:BS09012) 河北联合大学大学生创新性实验计划项目(编号:X2011035) 国家教育部新教师基金项目(编号:20102134120007) 辽宁省博士启动基金项目(编号:20101109) 唐山市科学技术研究与发展计划项目(编号:1113020486)
关键词 肿瘤坏死因子-Α 缓激肽 血肿瘤屏障 Tumor necrosis factor-alpha Bradykinin Blood-tumor barrier
  • 相关文献

参考文献4

二级参考文献37

  • 1陈建文,张俊平,程金建,陈建良,史鸿浏,张俊英,牟永告,张湘衡,周旺宁,赛克,陈忠平.体外药敏试验指导的恶性脑胶质瘤预见性化疗[J].广东医学,2005,26(9):1183-1185. 被引量:17
  • 2李波,朱世强,陆永建,王进钢,曾白云.神经导航辅助显微手术切除脑转移瘤[J].广州医药,2006,37(4):1-3. 被引量:2
  • 3吴慧,李善泉,万杰青,戴炯,朱志安.替尼泊甙加司莫司汀联合化疗对术后脑胶质瘤的疗效分析[J].中国临床神经外科杂志,2006,11(12):755-756. 被引量:6
  • 4金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 5Park S H, Ramachandran S, Kwon S H, et al. Upregulation of ATP-sensitive potassium channels for estrogen-mediated cell proliferation in human uterine leiomyoma cells [J]. GynecoL Endocrinol, 2008,24(5 ) : 250-256.
  • 6Ningaraj N S, Sankpal U T, Khaitan D, et al. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival [J]. Eur J Pharmacol. 2009,602(2-3):188-193.
  • 7Wondergem R, Cregan M, Strickler L, et al. Membrane potassium channels and human bladder tumor cells :Ⅱ. Growth properties [J ]. J.Membr. Biol, 1998, 161 (3) : 257-262.
  • 8Vitaz T W, Warnke P C, Tabar V, et al. Brach therapy for brain tumors [ J ]. J Neurooncol, 2005,73 ( 1 ) : 71-86.
  • 9Yin L T, Fu Y J, Xu Q L, et al. Potential biochemical therapy of glioma cancer [J]. Biochem Biophys Res Commun, 2007,362 (2) : 225-229.
  • 10Ahaner C. Glioblastoma and stem ceils [J]. Neoplasma., 2008, 55 (5) : 369-374.

共引文献26

同被引文献14

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部